ClinicalTrials.gg
Not yet recruitingNCT07235735Updated Sep 21, 2026

The Effect of Laughter Yoga on Individual and Organizational Outcomes in Nurse Managers

An interventional study of Laughter Yoga Program in Burnout, Professional, Stress, Psychological and Compassion Fatigue, sponsored by Zonguldak Bulent Ecevit University. Not yet recruiting. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Zonguldak Bulent Ecevit University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Sex
All
01

Study summary

The goal of this clinical trial is to learn if laughter yoga can improve both individual and organizational outcomes in nurse managers. The main questions it aims to answer are:

  • Does laughter yoga lower burnout and stress levels in nurse managers?
  • Does laughter yoga improve work-life quality and job performance?
  • Does laughter yoga help nurse managers make better decisions and solve problems more effectively?
  • Does laughter yoga lower compassion fatigue and support positive approaches to workplace conflict? Researchers will compare a laughter yoga group with a control group to see if there are meaningful differences.

Participants will:

  • Join structured laughter yoga sessions for a defined period (weekly sessions).
  • Complete surveys before and after the program about stress, burnout, work-life quality, decision-making, problem solving, job performance, compassion fatigue, and conflict approaches.
  • Continue their usual work while attending sessions.
Read the detailed description

Nurse managers play a vital role in healthcare systems by ensuring the quality of nursing services, supporting staff, coordinating care, and solving organizational problems. However, the combination of administrative responsibilities, staff shortages, and high expectations often leads to stress, burnout, compassion fatigue, and difficulties in maintaining work-life balance. These conditions not only affect the individual health and well-being of nurse managers but also reduce team motivation, patient care quality, and overall organizational performance.

Laughter yoga is a mind-body practice that combines intentional laughter with breathing exercises. It does not rely on humor or jokes; instead, participants engage in guided group exercises that promote spontaneous and prolonged laughter. Scientific evidence suggests that laughter yoga can lower stress hormones, increase endorphins, improve mood, and strengthen social bonds. Although laughter yoga has been studied in various populations, there is a lack of randomized controlled trials (RCTs) specifically focusing on nurse managers and their professional challenges.

This randomized controlled trial aims to fill this gap by evaluating the individual and organizational outcomes of laughter yoga among nurse managers working in university and state hospitals.

The expected contribution of this study is to provide new evidence on a cost-effective, non-pharmacological intervention that can be easily integrated into hospital settings. If laughter yoga proves effective, it can be adopted as a sustainable strategy to support nurse managers' mental health, enhance their leadership capacity, and indirectly improve patient care and organizational outcomes.

02

Conditions studied

  • Burnout, Professional
  • Stress, Psychological
  • Compassion Fatigue
  • Quality of Life
  • Decision Making
  • Problem Solving
  • Work Performance

Keywords

  • Nurse Managers
  • Laughter Yoga
  • Burnout
  • Stress
  • Work-Life Balance
  • Decision Making
  • Problem Solving
  • Job Performance
  • Compassion Fatigue
  • Conflict Management
  • Organizational Outcomes
  • Professional Development
03

In context

Burnout, Professional

216 studies on the registry are indexed under Burnout, Professional; 33 are open to participants now.

This study's planned enrollment of 80 is close to the median of 80 across 161 interventional studies indexed under Burnout, Professional.

Browse Burnout, Professional studies →

Lead sponsor

Zonguldak Bulent Ecevit University is the lead sponsor of 100 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Currently working as a nurse manager
  • Having at least six months of managerial experience
  • Continuing to serve as a nurse manager throughout the study period

Exclusion criteria

Exclusion Criteria:

  • Having previously received laughter yoga training
  • Use of medications affecting general health components during the study (e.g., for depression, anxiety)
  • Being pregnant
  • Experiencing an acute stressful life event, such as the death of a close relative
  • Having undergone abdominal surgery within the past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Experimental: Laughter Yoga

    Structured group-based laughter yoga sessions, 2 times per week, 30-45 minutes each, for 8 weeks.

    Behavioral: Laughter Yoga Program

  • No intervention
    Control

    Participants continue their routine work duties without any additional intervention.

Interventions

  • BehavioralLaughter Yoga Program

    This intervention consists of a structured Laughter Yoga Program designed for nurse managers. Each session includes breathing exercises, warm-up activities, guided and simulated laughter exercises (such as clapping, chanting, role-play laughter), and a short relaxation/meditation phase. Sessions are conducted in small groups by a certified facilitator. The program is delivered twice weekly for 8 weeks, with each session lasting approximately 30-45 minutes. The intervention is intended to reduce burnout, stress, and compassion fatigue, while improving decision-making, problem-solving, job performance, and work-life balance.

    Also known as: Laughter Therapy;, Laughter Exercises

06

What researchers measure

Primary outcomes

  1. Perceived Stress (Perceived Stress Scale - PSS)

    Developed by Cohen \& Williamson, adapted to Turkish by Eskin in 2013. 14 items, single-factor measure of stress. Scale Range: 0-56. Interpretation Higher scores = greater perceived stress (worse outcome).

    Time frame: Baseline, 8 weeks, 3 months.

  2. Burnout Levels (Maslach Burnout Inventory - MBI)

    Developed by Maslach \& Jackson in 1986, adapted to Turkish by Ergin in1992. 22 items, three subscales: Emotional Exhaustion, Depersonalization, and Personal Accomplishment. Scale Range: Emotional Exhaustion (0-54), Depersonalization (0-30), Personal Accomplishment (0-48). Interpretation: Higher Emotional Exhaustion and Depersonalization scores = worse outcome; higher Personal Accomplishment scores = better outcome.

    Time frame: Baseline, immediately post-intervention (8 weeks), and follow-up (3 months after intervention).

Secondary outcomes

  1. Problem Solving Inventory

    Problem Solving Inventory, Developed by Heppner \& Peterson in1982; adapted to Turkish by Şahin in 1993 Description: 31 items, six subscales: Problem-Solving Confidence, Approach-Avoidance, Personal Control, Planfulness, Impulsivity, Reflective Style. Scale Range: 31-186. Interpretation: Higher scores = less effective problem solving (worse outcome); lower scores = better problem-solving skills.

    Time frame: Baseline, 8 weeks, 3 months

  2. Work Performance

    Work Performance Job Performance Scale - Goodman and Svyantek in 1999; Turkish adaptation was made in 2014 by Bağcı. Description: 25 items, two subscales: Task Performance and Contextual Performance. Scale Range: 25-125. Interpretation: Higher scores = better work performance.

    Time frame: Baseline, 8 weeks, 3 months.

  3. Compassion Fatigue

    Developed by Dennis Portnoy and adapted Turkısh by Özdemir and Kutlu in 2022. The form consists of 40 items. The scale, which has no sub-dimensions, is evaluated based on the total number of items. The scale is a 3-point Likert-type scale: 1 = Very true, 2 = Partly true, and 3 = Rarely true. Those who answered "Very true" to 15 or more items in total are considered to have high levels of compassion fatigue.Cronbach alpha is 0,87

    Time frame: Baseline, 8 weeks, 3 months

  4. Decision-Making Styles scale

    Developed by Scott and Bruce in 1995; adapted to Turkish by Yılmaz Kuşaklı in 2023 24 items, five subscales: Rational, Intuitive, Dependent, Avoidant, Spontaneous. Scale Range: 24-120. Interpretation: Higher scores in each subscale = more frequent use of that decision-making style

    Time frame: Baseline, 8 weeks, 3 months.

07

Study locations

No study locations are listed for this record.

08

References and documents

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Dec 2026, 3 months later.

Of 128 non-industry interventional studies with no phase under Burnout, Professional, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 22. This study's planned 3 months is below that.

Counting every sponsor, half of 132 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2025
First posted
Nov 19, 2025
StartEst.
Sep 1, 2026
Primary completionEst.
Dec 17, 2026
CompletionEst.
Mar 17, 2027
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07235735
Responsible party
SERPİL SUBAŞI ÇAĞLAR (lecturer in the department of nursing management, Zonguldak Bulent Ecevit University) — Principal investigator
First posted
Nov 19, 2025
Start date
Sep 1, 2026 (estimated)
Primary completion
Dec 17, 2026 (estimated)
Completion
Mar 17, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Serpil SUBAŞI ÇAĞLAR, PhDCandidate
Contact
serpilkercaglar@hotmail.com
+905321709457
Handan ALAN, Assoc.Prof.
Contact
handanalan@yahoo.com
+905321709457

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion